The hubinar is now live via this link: https://investors.n4pharma.com/activity-updates/n4-pharma-hubinar-insight-into-the-sri-collaboration.
If you have additional questions, please submit them via the link and our team will respond as soon as they can.
Share your feedback
Questions (0)
Your question will be sent privately to Thalia Therapeutics. The company may choose to make this question public.
Start the conversation
Ask Thalia Therapeutics a question about this announcement.
Discover
